Clinical Management of Hand-Foot Syndrome Reaction Associated with Regorafenib Treatment

Daniel Ahn, DO, MS

Subscribe

Supported by Ask the Experts

Clinical Management of Hand-Foot Syndrome Reaction Associated with Regorafenib Treatment

Ask the Experts

Videos

Tanios S. Bekaii-Saab, MD, FACP

Professor, Mayo Clinic College of Medicine and Science
Program Leader, Gastrointestinal Cancer,
Mayo Clinic Cancer Center Consultant
Mayo Clinic, Phoenix, AZ

Daniel Ahn, DO, MS

Assistant Professor of Medicine
Mayo Clinic, AZ

Dr. Bekaii-Saab and Dr. Ahn describe the clinical implications of preemptive use of steroid cream and provide recommendations for patients in the management of hand-foot syndrome reaction.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.

Clinical Management of Hand-Foot Syndrome Reaction Associated with Regorafenib Treatment

Related Items

Subscribe Today!

I'd like to receive: